ALTIMMUNE, INC. Stock Issued During Period, Shares, New Issues
ALTIMMUNE, INC. (ALT) reported Stock Issued During Period, Shares, New Issues of 3.37 million shares for the 0-month period ending 2020-07-16, per its 10-K filed 2021-02-25.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2021-02-25
- 2020-07-16: Stock Issued During Period, Shares, New Issues 0 month 3.37M shares.
- 2013-12-31: Stock Issued During Period, Shares, New Issues 9 month 3.88M shares.
- 2011-06-30: Stock Issued During Period, Shares, New Issues 1 month 1.86M shares.
- 2010-11-30: Stock Issued During Period, Shares, New Issues 1 month 4.95M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues 1 month | Stock Issued During Period, Shares, New Issues 9 month |
|---|---|---|---|
| 2020-07-16 | 3.37M shares 10-K · filed 2021-02-25 | ||
| 2013-12-31 | 3.88M shares 10-K · filed 2014-03-11 | ||
| 2011-06-30 | 1.86M shares 10-K · filed 2014-03-11 | ||
| 2010-11-30 | 4.95M shares 10-K · filed 2013-03-14 | ||
| 2010-07-31 | 2.79M shares 10-K · filed 2013-03-14 | ||
| 2010-04-30 | 1.67M shares 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |